Angiotensin Converting Enzyme Inhibitors – beneficial effects seen in many patient groups may not extend to kidney transplant recipients

Access status:

Open Access

Field	Value	Language
dc.contributor.author	Cross, Nicholas B
dc.contributor.author	Webster, Angela C
dc.date.accessioned	2020-05-19
dc.date.available	2020-05-19
dc.date.issued	2016-03-01
dc.identifier.citation	Cross NB, Webster AC. Angiotensin Converting Enzyme Inhibitors – beneficial effects seen in many patient groups may not extend to kidney transplant recipients. Transplantation 2016;100(3): 472-3	en_AU
dc.identifier.uri	https://hdl.handle.net/2123/22318
dc.language.iso	en	en_AU
dc.publisher	Wolters Kluwer Health, Inc	en_AU
dc.rights	This is a pre-copyedited, author-produced version of an article accepted for publication in [Transplantation] following peer review. The version of record [Cross NB, Webster AC. Angiotensin Converting Enzyme Inhibitors – beneficial effects seen in many patient groups may not extend to kidney transplant recipients. Transplantation 2016;100(3): 472-3] is available online at: https://insights.ovid.com/article/00007890-201603000-00004 [DOI: 10.1097/TP.0000000000001140].	en_AU
dc.title	Angiotensin Converting Enzyme Inhibitors – beneficial effects seen in many patient groups may not extend to kidney transplant recipients	en_AU
dc.type	Article	en_AU
dc.identifier.doi	10.1097/TP.0000000000001140
dc.type.pubtype	Post-print	en_AU